Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organoheterocyclic compounds
(total 34 related compounds in database, current show from 21 to 30)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
3-(4-Chloro-phenyl)-1,6-dimethyl-1H-pyrimido[5,4-e][1,2,4]triazine-5,7-dione Depiction based on curated SMILES N O CH 3 N O N CH 3 Cl N N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
3,3'-(1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn]-3,8-phenanthroline-2,7-diyl)dipropanoic acid Depiction based on curated SMILES O O OH O O N O O N HO Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
1H-Indole, 3-(2-pyridin-4-yl-thiazol-4-yl)- Depiction based on curated SMILES N N S HN Pseudomonas
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Harmon DE, et al. 2010. Antimicrob Agents Chemother
4-[1,3-dioxo-5-(4-oxo-4H-3,1-benzoxazin-2-yl)-1,3-dihydro-2H-isoindol-2-yl]benzoic acid Depiction based on curated SMILES OH O O N O N O O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid Depiction based on curated SMILES N N HO O CH 3 S Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-nitro-7-[(3-phenylpyrrolidin-1-yl)methyl]quinolin-8-ol Depiction based on curated SMILES N OH O N _ O + N Chlamydia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Enquist PA, et al. 2012. Bioorg Med Chem Lett
5-nitro-7-[(4-phenyl-1-piperazinyl)methyl]-8-quinolinol Depiction based on curated SMILES N OH O N N _ O + N Chlamydia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Enquist PA, et al. 2012. Bioorg Med Chem Lett
5-[3'-(4-methylphenyl)-1'-phenyl-5-(2-thienyl)-3,4-dihydro-1'H,2H-3,4'-bipyrazol-2-yl]-5-oxopentanoic acid Depiction based on curated SMILES O S N N O OH N N CH 3 Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-({1-[(2-chloro-1,3-thiazol-5-yl)methyl]-1H-indol-3-yl}methylene)-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione Depiction based on curated SMILES Cl O CH 3 N O S H 3 C N N O N Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
5-{3-bromo-4-[(4-nitrobenzyl)oxy]benzylidene}pyrimidine-2,4,6(1H,3H,5H)-trione Depiction based on curated SMILES _ O O + N Br O HN O NH O O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3  4 



Back to top
2004-2024 NIPB, CAMS&PUMC